Cooley advised Akeso, Inc. on the offering.Akeso, Inc. (Hong Kong Exchange code: 9926.HK), a commercial-stage biopharmaceutical company, announced its HK$1.2 billion (appr. USD$153.29 million) follow-on public offering….
Akeso’s HK$1.2 Billion Follow-On Offering
![](https://globallegalchronicle.com/wp-content/uploads/2024/04/akesos-hk1-2-billion-follow-on-offering_660fab2e85845-480x360.jpeg)